TEVA PHARMACDRN revenue breakdown overview

TEVA PHARMACDRN revenue for the last year amounted to 101.26 B BRL, the most of which — 104.20 B BRL — came from its highest performing source at the moment, Generics, Innovative Medicines and Biopharmaceuticals, the year earlier bringing 78.25 B BRL. The greatest contribution to the revenue figure was made by United States — last year it brought TEVA PHARMACDRN 50.60 B BRL, and the year before that — 40.12 B BRL.